DrugInsight: Multi-Source Evidence Fusion for Explainable Drug-Drug Interaction Prediction Using Graph Neural Networks
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT · 13.04.2026 · 10 (04) · 1-9
DOI: 10.55041/ijsrem58550 ↗Kurz gefasst
Fachartikel in der Zeitschrift INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT, online erschienen am 13.04.2026. Verfasst von Ayman Uzayr und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Abstract—DrugInsight is an end-to-end, interpretable drug- drug interaction (DDI) prediction system. It evaluates interaction probability and severity while generating structured clinical explanations. The system utilizes RDKit and PyTorch Geometric to process drug SMILES strings into molecular graphs. These graphs are encoded by an AttentiveFP Graph Neural Network (GNN) into fixed-length structural embeddings. The embed- dings are concatenated with a comprehensive 12-dimensional pharmacological feature vector. This vector encompasses shared biological entities from DrugBank and post-market safety signals (PRR) from the TWOSIDES database. A Multi-Layer Perceptron (MLP) binary classifier processes this combined representation. The final interaction probability is computed using a tiered fusion model. This model adaptively weights curated DrugBank rules, ML classifier scores, and TWOSIDES pharmacovigilance signals to generate a unified risk index and severity classification. The system achieves a validation AUC of 0.7065 under a rigorous cold-start drug-level split. This demonstrates robust generaliza- tion to entirely unseen compounds. DrugInsight ensures high transparency through a rule-based explainer detailing metabolic competition, pharmacodynamic overlap, and explicit clinical rec- ommendations. The system is packaged for versatile deployment via a Streamlit web interface, a FastAPI REST endpoint, and a command-line interface (CLI). Index Terms—Drug-drug interactions, graph neural networks, AttentiveFP, evidence fusion, explainability, pharmacovigilance, DrugBank, TWOSIDES
Zitieren
APA
Uzayr, A., Meraj, M., Khan, M., & Prathyusha, R. (2026). DrugInsight: Multi-Source Evidence Fusion for Explainable Drug-Drug Interaction Prediction Using Graph Neural Networks. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT, 10(04), 1-9. https://doi.org/10.55041/ijsrem58550
Vancouver
Uzayr A, Meraj M, Khan M, Prathyusha R. DrugInsight: Multi-Source Evidence Fusion for Explainable Drug-Drug Interaction Prediction Using Graph Neural Networks. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT. 2026;10(04):1-9. doi:10.55041/ijsrem58550
BibTeX
@article{Uzayr2026,
author = {Uzayr, Ayman and Meraj, Mustafa and Khan, Motassim and Prathyusha, . R.},
title = {DrugInsight: Multi-Source Evidence Fusion for Explainable Drug-Drug Interaction Prediction Using Graph Neural Networks},
journal = {INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT},
year = {2026},
volume = {10},
number = {04},
pages = {1--9},
doi = {10.55041/ijsrem58550}
}
EUVIMED